BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 29562706)

  • 1. Amino Acid Transporters and Glutamine Metabolism in Breast Cancer.
    Cha YJ; Kim ES; Koo JS
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino Acid transporters in cancer and their relevance to "glutamine addiction": novel targets for the design of a new class of anticancer drugs.
    Bhutia YD; Babu E; Ramachandran S; Ganapathy V
    Cancer Res; 2015 May; 75(9):1782-8. PubMed ID: 25855379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamine metabolism in breast cancer and possible therapeutic targets.
    Li S; Zeng H; Fan J; Wang F; Xu C; Li Y; Tu J; Nephew KP; Long X
    Biochem Pharmacol; 2023 Apr; 210():115464. PubMed ID: 36849062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered glutamine metabolism in breast cancer; subtype dependencies and alternative adaptations.
    El Ansari R; McIntyre A; Craze ML; Ellis IO; Rakha EA; Green AR
    Histopathology; 2018 Jan; 72(2):183-190. PubMed ID: 28771772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamine transporters in mammalian cells and their functions in physiology and cancer.
    Bhutia YD; Ganapathy V
    Biochim Biophys Acta; 2016 Oct; 1863(10):2531-9. PubMed ID: 26724577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino acid transporters within the solute carrier superfamily: Underappreciated proteins and novel opportunities for cancer therapy.
    Hushmandi K; Einollahi B; Saadat SH; Lee EHC; Farani MR; Okina E; Huh YS; Nabavi N; Salimimoghadam S; Kumar AP
    Mol Metab; 2024 Jun; 84():101952. PubMed ID: 38705513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino Acids and Their Transporters in T Cell Immunity and Cancer Therapy.
    Wang W; Zou W
    Mol Cell; 2020 Nov; 80(3):384-395. PubMed ID: 32997964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzylserine inhibits breast cancer cell growth by disrupting intracellular amino acid homeostasis and triggering amino acid response pathways.
    van Geldermalsen M; Quek LE; Turner N; Freidman N; Pang A; Guan YF; Krycer JR; Ryan R; Wang Q; Holst J
    BMC Cancer; 2018 Jun; 18(1):689. PubMed ID: 29940911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone metastatic breast cancer cells display downregulation of PKC-ζ with enhanced glutamine metabolism.
    Tandon M; Othman AH; Winogradzki M; Pratap J
    Gene; 2021 Apr; 775():145419. PubMed ID: 33444686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of amino acid moieties to lapatinib increases the anti-cancer effect via amino acid transporters.
    Maeng HJ; Kim ES; Chough C; Joung M; Lim JW; Shim CK; Shim WS
    Biopharm Drug Dispos; 2014 Jan; 35(1):60-9. PubMed ID: 24151179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of cellular proliferation alters glutamine transport and metabolism in human hepatoma cells.
    Bode BP; Souba WW
    Ann Surg; 1994 Oct; 220(4):411-22; discussion 422-4. PubMed ID: 7944654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing unexpected interactions of a glutamine transporter inhibitor with members of the SLC1A transporter family.
    Freidman NJ; Briot C; Ryan RM
    J Biol Chem; 2022 Aug; 298(8):102178. PubMed ID: 35752361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino acid transporters as modulators of glucose homeostasis.
    Bröer S
    Trends Endocrinol Metab; 2022 Feb; 33(2):120-135. PubMed ID: 34924221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aphid amino acid transporter regulates glutamine supply to intracellular bacterial symbionts.
    Price DR; Feng H; Baker JD; Bavan S; Luetje CW; Wilson AC
    Proc Natl Acad Sci U S A; 2014 Jan; 111(1):320-5. PubMed ID: 24367072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ.
    Edwards DN; Ngwa VM; Wang S; Shiuan E; Brantley-Sieders DM; Kim LC; Reynolds AB; Chen J
    Sci Signal; 2017 Dec; 10(508):. PubMed ID: 29208682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino acid transporters as emerging therapeutic targets in cancer.
    Saito Y; Soga T
    Cancer Sci; 2021 Aug; 112(8):2958-2965. PubMed ID: 34091991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5).
    Cormerais Y; Massard PA; Vucetic M; Giuliano S; Tambutté E; Durivault J; Vial V; Endou H; Wempe MF; Parks SK; Pouyssegur J
    J Biol Chem; 2018 Feb; 293(8):2877-2887. PubMed ID: 29326164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino Acid Transporters as Disease Modifiers and Drug Targets.
    Bröer S
    SLAS Discov; 2018 Apr; 23(4):303-320. PubMed ID: 29557284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAT4 levels control amino-acid sensitivity of rapamycin-resistant mTORC1 from the Golgi and affect clinical outcome in colorectal cancer.
    Fan SJ; Snell C; Turley H; Li JL; McCormick R; Perera SM; Heublein S; Kazi S; Azad A; Wilson C; Harris AL; Goberdhan DC
    Oncogene; 2016 Jun; 35(23):3004-15. PubMed ID: 26434594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond.
    Ganapathy V; Thangaraju M; Prasad PD
    Pharmacol Ther; 2009 Jan; 121(1):29-40. PubMed ID: 18992769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.